BURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric disorders, today announced an upcoming presentation at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting. Presentation details: Title: Pharmacokinetic/Pharmacodynamic Analysis of the BNC210 Attune Phase 2b Dataset Enables Dose Selection for Planned Phase 3 PTSD St ...

Entered into Forbearance Agreement with Lender Group Reduced Management Fees Suspended Quarterly Distribution on Common Shares Received Notice of Late Filing from NYSE WESTPORT, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI”) today provided an update on steps it is taking to enhance liquidity and reduce costs in the wake of its announcement that it is investigating, and has preliminarily identified irregularities in, the financing, accounting, and inventory practices at its ...

ENGLEWOOD, Colo., May 27, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in sustainable aviation fuel and renewable chemicals, announced today the appointment of James J. Barber, Ph.D., to its Board of Directors. Dr. Barber brings decades of executive leadership and board experience in public and private companies including fuels, chemicals, biobased materials, micro-optics, carbon nanofibers, joint ventures and licensing. Dr. Barber currently serves on the board of directors of Graham Corpora ...

I've not written a public article about Nu Holdings (NYSE: NU ) before, but I picked this stock at $4.47 at Potential Multibaggers and have written dozens of articles and updates about the company. It's one of the best companiesPotential Multibaggers focuses on stocks that have the potential to go up 10x or more over the next decade. Potential Multibaggers is for long-term investors who want to fill their portfolio with potentially life-changing returns and have the patience and equanimity to hold through v ...

Todd McKinnon, CEO and co-founder of Okta, speaks during the BoxWorks 2019 Conference in San Francisco, California, on Oct. 3, 2019.Okta reported better-than-expected earnings and revenue on Tuesday but maintained its guidance as the identity management software vendor grapples with an uncertain economic backdrop. The stock plunged 11% in extended trading.Here's how the company did compared to LSEG estimates:EPS: 86 cents adjusted vs. 77 cents expectedRevenue: $688 million vs. $680 million expectedRevenue i ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Rob Katz to return as CEOCompany reaffirms fiscal 2025 guidance and pass sales trends provided in the April metrics releaseBROOMFIELD, Colo., May 27, 2025 /PRNewswire/ -- Vail Resorts, Inc. (NYSE: MTN) today announced that Rob Katz, current Executive Chairperson and former Chief Executive Officer, has been appointed CEO of the Company. Katz, age 58, succeeds Kirsten Lynch, who has stepped down as CEO and as a director of the Board. Lynch will remain in an advisory role to the Company for an interim period t ...

NEW YORK, May 27, 2025 /PRNewswire/ -- Safehold Inc. (NYSE: SAFE), the creator and leader of the modern ground lease industry, has closed on a ground lease to facilitate the development of The Benjamin, a ground-up, 364-unit multifamily development in the Boston MSA. The deal is Safehold's first with The Michaels Organization, a large-scale national multifamily investor, developer and operator. "We're pleased to see the growing adoption of our ground lease solution for multifamily projects in top MSAs," sa ...

Analysis Shows 23% Reduction in Morphine Use with Favorable Safety Profile in Patients 60 Years of Age and OlderNASHVILLE, Tenn., May 27, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, today announced the publication of its study investigating Caldolor® (intravenous ibuprofen) in older patients. The analysis evaluated the safety and efficacy of Caldolor for the management of pain and fever in patients 60 years of age and older. It marks an important ...

Core Insights - Senstar Technologies Corporation reported strong financial results for the first quarter of 2025, highlighting double-digit revenue growth and significant improvements in gross and EBITDA margins [2][3][5]. Financial Performance - Revenue for Q1 2025 was $8.4 million, a 12.5% increase from $7.5 million in Q1 2024 [3][8]. - Gross profit reached $5.7 million, representing a gross margin of 67.2%, up from 59.6% in the previous year [3][8]. - Operating income was $1.0 million compared to an operating loss of $73,000 in the same quarter last year [5][8]. - Net income for Q1 2025 was $1.0 million, or $0.04 per share, compared to a net loss of $0.7 million, or ($0.03) per share, in Q1 2024 [5][8]. - EBITDA for the first quarter was $1.2 million, a significant increase from $114,000 in Q1 2024 [6][8]. Cost Management - Operating expenses were $4.6 million, a slight increase of 2% from $4.5 million in Q1 2024, primarily due to targeted marketing and selling expenses [4][8]. - The increase in gross margin was attributed to a balanced product mix, cost optimization, and efficient cost control [3][8]. Cash Position - As of March 31, 2025, cash and cash equivalents, along with short-term bank deposits, totaled $22 million, up from $20.6 million at the end of 2024 [6][8]. Market Position - The company experienced strong demand across its core verticals, including Corrections, Energy, and Logistics, and noted growing global interest in its MultiSensor solution [2].